What is the B12 Test?
The B12 test is a blood test that measures vitamin B12 levels to diagnose deficiency, with two main options: total B12 (serum cobalamin) or active B12 (serum holotranscobalamin), either of which can be used as the first-line test. 1
Test Types and What They Measure
First-Line Testing Options
You have two acceptable choices for initial testing 1:
Total B12 (serum cobalamin): Measures all vitamin B12 in the blood
- Cost: £2 per test
- Widely available in local hospital laboratories
- Faster turnaround time
Active B12 (serum holotranscobalamin): Measures only the biologically active form of B12 that cells can actually use
- Cost: £18 per test
- More accurate theoretically, but lacks strong evidence to mandate its use over total B12
- Usually requires external referral laboratories
- Longer turnaround time
The key point: Either test is acceptable and preferable to not testing when you suspect deficiency based on symptoms, signs, or risk factors. 1
Interpreting Results
Total B12 Results 1:
- < 180 ng/L (133 pmol/L): Confirmed vitamin B12 deficiency
- 180-350 ng/L (133-258 pmol/L): Indeterminate—possible deficiency
- > 350 ng/L (258 pmol/L): Deficiency unlikely
Active B12 Results 1:
- < 25 pmol/L: Confirmed vitamin B12 deficiency
- 25-70 pmol/L: Indeterminate—possible deficiency
- > 70 pmol/L: Deficiency unlikely
When Indeterminate Results Occur
If your initial B12 test falls in the indeterminate range, consider measuring methylmalonic acid (MMA) as a confirmatory test. 1 MMA provides a more reliable diagnosis reflecting the functional status of vitamin B12, but it's unsuitable as first-line testing due to:
- High cost (£11-80 per test)
- Requires specialist analytical equipment
- Often needs external laboratory analysis
- Longer result turnaround time
Important caveat: MMA can be elevated in renal dysfunction regardless of B12 status, so interpret carefully in patients with elevated creatinine. 2
When to Order the Test
Order B12 testing when patients present with 1:
Clinical Signs/Symptoms:
- Anemia or macrocytosis on blood count
- Cognitive difficulties ("brain fog"), memory loss
- Visual problems (blurred vision, optic atrophy, visual field loss)
- Glossitis
- Neurological issues: peripheral neuropathy, balance problems, falls, impaired gait, pins and needles, numbness
- Unexplained fatigue
- Iron treatment not working during pregnancy/breastfeeding
Risk Factors:
- Dietary: Vegan/vegetarian diet, food allergies (eggs, milk, fish), inability to afford/prepare B12-rich foods
- Medical conditions: Atrophic gastritis, celiac disease, autoimmune conditions (thyroid disease, Sjögren syndrome, type 1 diabetes)
- Medications: Metformin, H2 receptor antagonists, colchicine, phenobarbital, pregabalin, primidone
- Surgical history: Bariatric surgery, gastrectomy, ileectomy
- Family history of B12 deficiency or autoimmune conditions
Special Populations
Do not apply standard testing recommendations to pregnant patients or those with suspected B12 deficiency from recreational nitrous oxide use—these require specialized guidance. 1
Clinical Context Matters
The diagnosis should not rely solely on biomarker concentrations. 3 Consider the complete clinical picture:
- Patients with clear etiology (e.g., post-gastrectomy, veganism) plus abnormal biomarkers have confirmed deficiency
- Patients with symptoms and abnormal biomarkers but unclear cause need specialist referral for causality assessment
- Isolated low B12 without symptoms or clear cause requires careful interpretation
Common pitfall: Specialists in neurology, hematology, or vascular medicine may miss B12 deficiency as a cause of their patient's presentation, particularly in thromboembolic disorders which can be inaugural manifestations of autoimmune gastritis with B12 deficiency. 3